ATAI Life Sciences N.V. Overview
ATAI Life Sciences N.V. Target Price
Analysts' 12-month price predictions for ATAI.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.19
Average Target Price
$12.33
137.6% upside
137.6% upside3 analysts in the last 4 months
High: $15 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-20 | Canaccord GenuitySumant Kulkarni | $15 | 189% upside |  |
| 2026-03-27 | Deutsche Bank | $12 | 131.2% upside | |
| 2026-03-06 | JefferiesAndrew Tsai | $10 | 92.7% upside | |
| 2026-01-20 | Guggenheim | $11 | 111.9% upside | |
| 2025-10-22 | Canaccord Genuity | $14 | 169.7% upside | |
| 2025-10-13 | Needham | $12 | 131.2% upside | |
| 2025-05-20 | JefferiesAndrew Tsai | $5 |  3.7% downside | |
| 2024-04-03 | Maxim GroupJason McCarthy | $6 | 15.6% upside | |